New Podcast Episode by PharmaSources!

[Pharma Sources]

View this E-mail (https://info.cphi-chinaedm.com/x/?S7Y1Mf2fa2tsYGJs.j.H1tTA3NTkf5GthaGxsZkBAAA05)  (https://info.cphi-chinaedm.com/x/?S7Y1Mf2fa2tsYGJs.j.H1tTA3NTkf5GthaGxsZkBAAA05)online

 (https://www.pharmasources.com/pharmavibe/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0331)
WELCOME TO
PharmaVibe
Podcast hosted by PharmaSources

Listen and sense the heartbeat of the industry through news stories, key conferences, and in-depth interviews encompassing an array of specialties, sectors, and areas.
Subscribe Now (https://www.pharmasources.com/pharmavibe/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0331)
 (https://www.pharmasources.com/pharmavibe/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0331)
Latest Release
 

 

EPISODE 9 | 9 MIN | 30 March 2022
#Drug Review  #Business  #R&D
Weekly Pharma News Review 
(Mar.21-Mar.25)
This week we collected 18 pieces of news in drug review, R&D, and business.

It is comforting to know that two drugs for the treatment of neuroblastoma from PersonGen and Ascentage Pharma have received the qualification of orphan drugs, which my reduce the risk of this severe disease after they were granted market approval.
Play (https://www.pharmasources.com/pharmavibe/detail/9.html/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0331)

 

Featured Episode
 

EPISODE 8 | 10 MIN | 23 Mar 2022
#Drug Review  #COVID-19  #Business  #R&D
Weekly News Review (Mar.14-Mar.18)
Play (https://www.pharmasources.com/pharmavibe/detail/8.html/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0331)

EPISODE 7 | 10 MIN | 16 Mar 2022
#Drug Review  #COVID-19  #Listing  #R&D
Weekly News Review (Mar.07-Mar.12)
Play (https://www.pharmasources.com/pharmavibe/detail/7.html/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0331)

PharmaVibe, the official podcast hosted by PharmaSources has debuted in Content Hub early this month. It provides an easy way to help you get firsthand market information in the Chinese and global markets, and follow the industry’s critical issues through news stories, key conferences and in-depth interviews.

Why not subscribe now and enjoy the FREE episodes to stay in tune with the industry experts, thought leaders, innovators as well as leading decision-makers.

Discover More (https://www.pharmasources.com/pharmavibe/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0331)

 (https://www.facebook.com/Pharmasources/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0331) (https://twitter.com/Pharmachina365/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0331) (https://www.linkedin.com/company/13436110/admin/?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0331)
 (https://www.pharmasources.com//?utm_source=EDM&utm_medium=online&am p;utm_campaign=enedmpodcast0331)Contact us
PharmaSources at imsinoexpo.com (mailto:PharmaSources at imsinoexpo.com)

If you no longer wish to receive our e-mail updates,
please go here to unsubscribe. (https://info.cphi-chinaedm.com/x/plugin/?pName=unsubscribe&MIDRID=S7Y1Mf2fa2tsYGJs.j.H1tTA3NTkf5GthaGxsZkBAAA05&Z=604749158)
   
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.nottingham.ac.uk/pipermail/affymetrix-arabidopsis/attachments/20220331/70e1c05b/attachment-0001.html>